Routine blood test predicts prognosis in aggressive skin cancer

Researchers at Fox Chase tie total number of lymphocytes to outcome in Merkel cell carcinoma

2012-10-31

(Press-News.org) BOSTON, MA (October 31, 2012)—A routine blood test may help predict survival in patients with an aggressive form of skin cancer known as Merkel cell carcinoma, according to new findings by Fox Chase Cancer Center researchers. The results will be presented on Wednesday, October 31 at the American Society for Radiation Oncology's 54th Annual Meeting.

"With such a fast-growing cancer, we get one question a lot: 'how long do I have?'," says Matthew Johnson, MD, a resident physician in the Department of Radiation Oncology at Fox Chase and lead author on the study. "That's usually hard to answer. These findings enable us to give a more educated response."

Specifically, Johnson and his colleagues found that patients with Merkel cell carcinoma who had low numbers of lymphocytes—a type of white blood cell that participates in immune function—didn't live as long after treatment as those with higher lymphocyte counts.

The difference was remarkable. Among people whose absolute lymphocyte count (ALC) was below the cutoff (1500 cells per cubic millimeter of blood, or 1.5 k/mm3), half survived 25 months or less after surgery, chemotherapy, or radiation. Among those with ALCs in the normal range, half lived close to 100 months or more following treatment. Disease-free survival was also much longer in patients with higher ALCs.

"Since ALC has been tied to prognosis in other types of cancer, we were expecting to see some difference between patients with high and low counts," says Johnson. "But it was definitely a bigger difference than what we were anticipating."

Merkel cell carcinoma is a rare and aggressive type of skin cancer, usually striking older people and those with weakened immune systems.

During the study, Johnson and his team reviewed medical records of 64 patients treated for Merkel cell carcinoma between 1992 and 2010 at Fox Chase. All patients had had their blood analyzed the month before surgery, chemotherapy, or radiation.

Approximately two-thirds of patients had a normal ALC. Along with having longer overall survival, these patients were much more likely to be disease-free 60 months later (67%) than those with a low ALC (24%).

ALC may be associated with survival because it's a marker of overall immune health, says Johnson, and healthier immune systems may keep a cancer in check so it doesn't continue to grow.

Doctors routinely check a patient's ALC as part of a standard blood count, says Johnson. They just typically don't know how to interpret those particular results. Since checking a patient's ALC is already routine, it would be "reasonable, based on our conclusions," for a patient to ask his or her doctor for the results of that test, he notes.

However, if a patient's ALC is particularly low, there's little the doctor would do differently to treat Merkel cell carcinoma, since such an aggressive cancer is always treated aggressively. But many patients believe it's helpful to know their prognosis, he says.

"ALC provides patients with some information about how long they may have left. There are a lot of patients who just want to know."

###Johnson's co-authors include Aruna Turaka, Fang Zhu, Thomas Galloway, Jeffrey Farma, and Clifford Perlis from Fox Chase.

Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence three consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, visit Fox Chase's Web site at www.foxchase.org or call 1-888-FOX CHASE or (1-888-369-2427).

ELSE PRESS RELEASES FROM THIS DATE:

Stars ancient and modern?

2012-10-31

This colourful view of the globular star cluster NGC 6362 was captured by the Wide Field Imager attached to the MPG/ESO 2.2-metre telescope at ESO's La Silla Observatory in Chile. This new picture, along with a new image of the central region from the NASA/ESA Hubble Space Telescope, provide the best view of this little-known cluster ever obtained. Globular clusters are mainly composed of tens of thousands of very ancient stars, but they also contain some stars that look suspiciously young. Globular star clusters are among the oldest objects in the Universe, and NGC 6362 ...

Higher risk of maternal complications/preterm deliveries for women undergoing multiple cesareans

2012-10-31

The risk of maternal complications and preterm deliveries is significantly higher for women undergoing their fifth or more caesarean section, finds a new study published today (31 October) in BJOG: An International Journal of Obstetrics and Gynaecology. The study explored the incidence of UK women having Multiple Repeat Caesarean Sections (MRCS), defined as five or more, and the outcomes for them and their babies compared to women having their second to fourth caesarean section. The researchers, from Imperial College Healthcare NHS Trust and the University of Oxford ...

Stereotactic radiosurgery shows promise for kidney cancer

2012-10-31

CLEVELAND – A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer. This non-invasive treatment technique may represent a potential new non-surgical option for patients with this deadly disease who have limited treatment options. Rod Ellis, MD, lead author of the study along with Lee Ponsky, MD, who is the Principal Investigator, presented results of a Phase 1 clinical trial in 20 patients with localized primary renal ...

Privately owned genetic databases may hinder diagnosis and bar the way to the arrival of personalized medicine

2012-10-31

In response to the on-line publication by the European Journal of Human Genetics today (Wednesday) of an article by US researchers led by Dr. Robert Cook-Degan, a former member of the US Office of Technology Assessment, showing that Myriad Genetics, providers of the BRCA1/2 genetic test in the US, has amassed vast quantities of clinical data without sharing it, Professor Martina Cornel, chair of the European Society of Human Genetics' Professional and Public Policy committee, said: "We are very concerned that such important data is being withheld from those who most need ...

Obese dogs at risk of health condition experienced by humans

2012-10-31

Veterinary scientists at the University of Liverpool have found that, like humans, obese dogs can experience metabolic syndrome, a condition that describes multiple health issues that occur in the body at the same time. The condition occurs when a number of health problems, such as increased blood glucose and increased cholesterol levels, develop together, with the potential to increase the risk of other diseases, such as cardiovascular disease and diabetes. Although canine obesity is known to cause insulin resistance, mild hypertension, and high blood cholesterol ...

Health inequalities could be reduced by more effective health care, says new study

2012-10-31

Wide differences in death rates from disease still persist throughout England – but effective healthcare can help to reduce these inequalities, a new study has discovered. Researchers from the University of Leicester led a two-year project funded by the National Institute for Health Research (NIHR) into why differences in death rates from diseases like heart disease, strokes, lung disease and cancers still persist. They found that age and poverty were among the biggest factors that accounted for the differences – but they also discovered that effective delivery of healthcare ...

Navy oceanographers delve deeper in wave data to improve forecasts

2012-10-31

WASHINGTON--Around the globe, mariners and navies alike have long observed and included weather and sea states in navigational planning when plotting course or developing military strategy. And although forecasting had become an integral function by the start of the 20th century, these predictions were often crude and qualitative. For the U.S. Navy, the years 1941 through 1946 provided an unusual stimulus to ocean wave research, according to pioneer World War II oceanographer Charles Bates. During this brief five-year period, theory, observation, and prediction of sea, ...

Sustainable cities must look beyond city limits

2012-10-31

City leaders aspiring to transform their cities into models of sustainability must look beyond city limits and include in their calculation the global flow of goods and materials into their realm, argue researchers in the Royal Swedish Academy of Sciences journal Ambio. Many cities are now developing sustainable strategies to reduce pollution and congestion, improve the quality of life of their citizens, and respond to growing concern about human impact on climate and the environment. But sustainable city initiatives often ignore the environmental footprint from imported ...

New metric to track prosthetic arm progress

2012-10-31

PROVIDENCE, R.I. [Brown University] — Amputees with a new prosthetic arm must learn how to use their device to perform everyday tasks that were once second nature. Taking off a shirt becomes a conscious, multistep effort: grasp the shirt, lift the shirt over the head, pull arms through the sleeves, place the shirt on the table, let go of the shirt. In the best cases of treatment, patients work with teams of doctors, prosthetists, and therapists to learn how their new limbs can help them regain function and quality of life. But clinicians have had few tools to assess ...

New hope for survivors of stroke and traumatic brain injury

2012-10-31

A new ground-breaking study about to be published in the Adis journal CNS Drugs provides clinical evidence that, for the first time, chronic neurological dysfunction from stroke or traumatic brain injury can rapidly improve following a single dose of a drug that targets brain inflammation, even years after the stroke or traumatic event. The observational study¹ of 629 patients, conducted over the course of nearly two years, documents a diverse range of positive effects, including statistically significant rapid clinical improvement in motor impairment, spasticity, cognition, ...

Routine blood test predicts prognosis in aggressive skin cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: